封面
市场调查报告书
商品编码
1591790

幽门螺旋桿菌诊断市场:按技术、按最终用户划分 - 2025-2030 年全球预测

Helicobacter Pylori Diagnostics Market by Technology (Immunoassays, Molecular Diagnostics, POC), End User (Clinics, Diagnostics Laboratories, Hospitals) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年幽门螺旋桿菌诊断市值为7.5281亿美元,预计到2024年将达到8.2228亿美元,复合年增长率为9.71%,到2030年将达到14.4046亿美元。

幽门螺旋桿菌(H. pylori)诊断市场是胃肠病学的关键市场,专注于幽门螺旋桿菌引起的感染疾病的检测和管理,幽门螺旋桿菌因与消化性溃疡和胃癌有关而臭名昭着。该市场包括多种诊断方法,从呼吸检测、粪便检验和切片检查等无创技术,到内视镜活检和 PCR 测试等侵入性方法。幽门螺旋桿菌准确诊断的必要性源自于幽门螺旋桿菌与胃肠道疾病密切相关,早期准确检测对于优化治疗效果和预防併发症至关重要。诊断技术已应用到各个地方,包括医院、诊断实验室和诊所,全球对个人化医疗的推动也越来越重视即时检测。市场的成长是由患病率的增加、诊断准确性的技术进步以及公众对胃肠道健康意识的提高所推动的。然而,先进诊断工具高成本、报销政策不一致以及潜在的抗生素抗药性等挑战正在阻碍市场扩张。关键的成长机会存在于快速且具成本效益的筛检技术的开发中,特别是在医疗保健机会有限的新兴市场。对自动化诊断平台的研发投资以及预测诊断人工智慧的整合可以带来突破。鼓励企业专注于与医疗保健提供者合作,并投资用于远距离诊断的远端医疗技术。儘管存在监管障碍和欠发达地区缺乏意识等限制,但该市场尤其受到非侵入性检测解决方案、人工智能主导的分析工具以及支持基于价值的护理的综合医疗网络的推动,这提供了一条利润丰厚的创新路径。为了真正脱颖而出,公司应优先考虑旨在传播医疗专业人员幽门螺旋桿菌检测通讯协定的培训计划,以确保全面的市场渗透和持续成长。

主要市场统计
基准年[2023] 75281万美元
预测年份 [2024] 82228万美元
预测年份 [2030] 1,440.46 百万美元
复合年增长率(%) 9.71%

市场动态:快速发展的幽门螺旋桿菌诊断市场的关键市场洞察

供需的动态交互作用正在改变幽门螺旋桿菌诊断市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病流行率不断上升
    • 提高人们对幽门螺旋桿菌的认识
    • 对早期发现症状的需求不断增长
  • 市场限制因素
    • 严格的政府监管标准
  • 市场机会
    • 对个人化抗生素治疗的需求不断增长
    • 诊断技术进步迅速成长
  • 市场挑战
    • 来自竞争市场的竞争定价压力

波特五力:驾驭幽门螺旋桿菌诊断市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解幽门螺旋桿菌诊断市场的外部影响

外部宏观环境因素在塑造幽门螺旋桿菌诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解幽门螺旋桿菌诊断市场的竞争状况

对幽门螺旋桿菌诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的见解,以应对日益激烈的竞争。

FPNV 定位矩阵幽门螺旋桿菌诊断市场供应商的绩效评估

FPNV定位矩阵是评估幽门螺旋桿菌诊断市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议,绘製幽门螺旋桿菌诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对幽门螺旋桿菌诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:全面分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病传播加剧
      • 提高人们对幽门螺旋桿菌的认识
      • 对早期发现症状的需求增加
    • 抑制因素
      • 严格的政府监管标准
    • 机会
      • 对个人化抗生素治疗的需求不断增加
      • 诊断产品技术进步迅速成长
    • 任务
      • 市场竞争带来价格战压力
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章幽门螺旋桿菌诊断市场:依技术分类

  • 免疫检测
  • 分子诊断
  • 证券

第七章 幽门螺旋桿菌诊断市场:依最终使用者分类

  • 诊所
  • 诊断实验室
  • 医院

第八章美洲幽门螺旋桿菌诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区幽门螺旋桿菌诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲幽门螺旋桿菌诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Alpha Laboratories Ltd.
  • Bio-Rad Laboratories, Inc
  • Biohit Oyj
  • CerTest BIOTEC
  • Coris BioConcept SPRL
  • Diasorin SPA
  • EKF Diagnostics Holdings PLC
  • Epitope Diagnostics, Inc.
  • Medline Industries, LP
  • Meridian Bioscience, Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • TechLab, Inc.
  • Thermo Fisher Scientific Holdings, Inc.
Product Code: MRR-CA17E905E785

The Helicobacter Pylori Diagnostics Market was valued at USD 752.81 million in 2023, expected to reach USD 822.28 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 1,440.46 million by 2030.

The Helicobacter Pylori (H. pylori) diagnostics market is pivotal in gastroenterology, focusing on the detection and management of infections caused by H. pylori bacteria, infamous for its role in peptic ulcers and gastric cancers. This market encompasses a variety of diagnostic modalities, including non-invasive techniques like breath, stool, and blood tests, as well as invasive methods such as endoscopy with biopsy and PCR tests. The necessity of accurate H. pylori diagnostics stems from the bacterium's significant contribution to gastrointestinal diseases, necessitating early and precise detection to optimize treatment efficacy and prevent complications. Diagnostics find applications across hospitals, diagnostic laboratories, and clinics, with a growing emphasis on point-of-care testing given the global push towards personalized medicine. Market growth is fuelled by increasing prevalence rates, technological advancements in diagnostic accuracy, and rising public awareness about gastrointestinal health. However, challenges such as the high cost of advanced diagnostic tools, inconsistent reimbursement policies, and potential antibiotic resistance hinder its expansion. Key growth opportunities exist in the development of rapid, cost-effective screening techniques, particularly in emerging markets where access to healthcare can be limited. Investment in R&D on automated diagnostic platforms and integration of artificial intelligence for predictive diagnostics offers potential breakthroughs. Companies are recommended to focus on partnerships with healthcare providers and invest in telemedicine technologies to tap into remote diagnostics. Despite limitations such as regulatory hurdles and low awareness in underdeveloped regions, the market presents lucrative innovation avenues, particularly in non-invasive testing solutions, AI-driven analytical tools, and integrated healthcare networks that support value-based care. To truly excel, businesses should prioritize training programs aimed at increasing the uptake of H. pylori testing protocols among healthcare professionals to ensure comprehensive market penetration and sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 752.81 million
Estimated Year [2024] USD 822.28 million
Forecast Year [2030] USD 1,440.46 million
CAGR (%) 9.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Helicobacter Pylori Diagnostics Market

The Helicobacter Pylori Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of infectious diseases
    • Increasing awareness of helicobacter pylori
    • Rise in demand early detection of symptoms
  • Market Restraints
    • Stringent regulatory norms by government
  • Market Opportunities
    • Emerging need for personalized antibiotic therapy
    • Surging technological advancement in diagnostics products
  • Market Challenges
    • Competitive pricing pressure due to highly competitive market

Porter's Five Forces: A Strategic Tool for Navigating the Helicobacter Pylori Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Helicobacter Pylori Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Helicobacter Pylori Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Helicobacter Pylori Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Helicobacter Pylori Diagnostics Market

A detailed market share analysis in the Helicobacter Pylori Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Helicobacter Pylori Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Helicobacter Pylori Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Helicobacter Pylori Diagnostics Market

A strategic analysis of the Helicobacter Pylori Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Helicobacter Pylori Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Laboratories Ltd., Bio-Rad Laboratories, Inc, Biohit Oyj, CerTest BIOTEC, Coris BioConcept SPRL, Diasorin S.P.A., EKF Diagnostics Holdings PLC, Epitope Diagnostics, Inc., Medline Industries, LP, Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, TechLab, Inc., and Thermo Fisher Scientific Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Helicobacter Pylori Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Immunoassays, Molecular Diagnostics, and POC.
  • Based on End User, market is studied across Clinics, Diagnostics Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases
      • 5.1.1.2. Increasing awareness of helicobacter pylori
      • 5.1.1.3. Rise in demand early detection of symptoms
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory norms by government
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging need for personalized antibiotic therapy
      • 5.1.3.2. Surging technological advancement in diagnostics products
    • 5.1.4. Challenges
      • 5.1.4.1. Competitive pricing pressure due to highly competitive market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Helicobacter Pylori Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunoassays
  • 6.3. Molecular Diagnostics
  • 6.4. POC

7. Helicobacter Pylori Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Diagnostics Laboratories
  • 7.4. Hospitals

8. Americas Helicobacter Pylori Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Helicobacter Pylori Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Helicobacter Pylori Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alpha Laboratories Ltd.
  • 3. Bio-Rad Laboratories, Inc
  • 4. Biohit Oyj
  • 5. CerTest BIOTEC
  • 6. Coris BioConcept SPRL
  • 7. Diasorin S.P.A.
  • 8. EKF Diagnostics Holdings PLC
  • 9. Epitope Diagnostics, Inc.
  • 10. Medline Industries, LP
  • 11. Meridian Bioscience, Inc.
  • 12. Quest Diagnostics Incorporated
  • 13. Quidel Corporation
  • 14. Sekisui Diagnostics, LLC
  • 15. TechLab, Inc.
  • 16. Thermo Fisher Scientific Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023